🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate efficacy of tolterodine extended release formulation compared w...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-05
Trial ID
NCT00139724
Treatments Being Tested
This is a Phase IV, prospective, randomized, multi-center study to find ris...
Status
Completed
Location
Samsung Medical Center
Start Date
2006-08
Trial ID
NCT00730535
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of toltero...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-03
Trial ID
NCT00645281
Treatments Being Tested
A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolter...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-10
Trial ID
NCT01521767
The study is intended to test the safety, tolerability, efficacy of two dos...
Status
Completed
Location
Multiple Locations
Start Date
2008-04-25
Trial ID
NCT00688688
Treatments Being Tested
The purpose of this Phase III study is to evaluate the efficacy and safety ...
Status
Completed
Location
Beijing Chaoyang Hospital
Start Date
2010-01
Trial ID
NCT01512004
Treatments Being Tested
Evaluation of use of low dose tadalafil 5 mg daily for treatment of female ...
Status
Completed
Location
Samer Morsy
Start Date
2020-12-01
Trial ID
NCT04500860
Treatments Being Tested
The study is designed to investigate the effects of the investigational dru...
Status
Terminated
Location
Multiple Locations
Start Date
2012-02-27
Trial ID
NCT01500382
Treatments Being Tested
The purpose of this study was to assess tolerability of mirabegron compared...
Status
Completed
Location
Site US10002 Urology Centers of Alabama
Start Date
2014-07-24
Trial ID
NCT02138747
Treatments Being Tested
This is an open-label (both the physician and healthy volunteer know which ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-05
Trial ID
NCT01566760